Tag:

Germany

Latest Headlines

Latest Headlines

Vectura will close plant in Germany within the year

U.K. respiratory drug specialist Vectura picked up a plant last year when it bought Germany's Activaero in a €130 million ($181 million) deal. But Vectura has decided it doesn't need it and will close the facility within a year in a cost-saving move.

Germany's cost watchdog decides Valeant's Provenge has added benefit after all

In January, Germany's cost watchdog decided that Dendreon's--now Valeant's--Provenge had no added benefit for men with metastatic prostate cancer. But now, it's changing its tune.

UPDATED: Germany, EU, join U.S. in banning India-made Ranbaxy products

Seemingly hand in hand with the U.S., German regulators have banned Ranbaxy Laboratories from exporting the antibiotic cephalosporin to their country following an inspection earlier this year of the company's plant in central India.

German meat company invests $30M in plant for traceable heparin ingredients

After tainted Chinese heparin in 2008 led to dozens of deaths of dialysis patients in the U.S., global regulators started touting the need for heparin makers to be able to track back sources to ensure they were safe. German meat company T ö nnies saw an opportunity there, bought a German heparin API maker and started building a brand-new plant. That facility was dedicated this week and will start producing heparin intermediates this year.

Germany's Aenova buys North Carolina packaging operation

Germany's Aenova has been in expansion mode. It pumped up production capacity with its acquisition last year of contract manufacturer Haupt Pharma and has now bought a U.S. company to help it boost its packaging capabilities. 

Germany first in Europe to test database for defeating counterfeits

Germany is implementing a system that allows the authenticity of drugs to be checked at the pharmacy level to protect against counterfeits.

Merck sells salt plant in Lehrte to Schüssler Novachem

Having already bought the land on which Merck KGaA's salt plant in Lehrte, Germany, sits, salt maker Schüssler Novachem has now bought the production and laboratory equipment from the German drugmaker.

Bayer expands German plants as it preps for new hemophilia treatments

The German drugmaker is feeling certain enough about a couple of potential hemophilia hits in its pipeline that it will spend nearly $700 million on new facilities in Germany that it says will add 500 jobs in its home country.

German med schools perfectly OK with pharma-rep visits and gifts

German med school deans aren't too concerned with pharma reps swaying their students' future prescription habits, according to a recent survey. 

PPD partners up to give Germany a starring role in clinical trials

PPD has signed a deal with a German hospital to help bring more clinical trials to the country, agreeing to lend its global reach and help lure drug developers.